NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma
NUTMEG:一项随机 II 期研究,比较纳武利尤单抗联合替莫唑胺与单用替莫唑胺治疗新诊断的老年胶质母细胞瘤患者的疗效。
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdad124
Sim, Hao-Wen; Wachsmuth, Luke; Barnes, Elizabeth H; Yip, Sonia; Koh, Eng-Siew; Hall, Merryn; Jennens, Ross; Ashley, David M; Verhaak, Roel G; Heimberger, Amy B; Rosenthal, Mark A; Hovey, Elizabeth J; Ellingson, Benjamin M; Tognela, Annette; Gan, Hui K; Wheeler, Helen; Back, Michael; McDonald, Kerrie L; Long, Anne; Cuff, Katharine; Begbie, Stephen; Gedye, Craig; Mislang, Anna; Le, Hien; Johnson, Margaret O; Kong, Benjamin Y; Simes, John R; Lwin, Zarnie; Khasraw, Mustafa